These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9601759)

  • 1. [A controlled clinical trial of methylprednisolone in patients with the cholestatic form of alcoholic liver cirrhosis].
    Hozo I; Mise S; Rumboldt Z; Bagatin J; Tonkić A
    Med Arh; 1996; 50(3-4):81-3. PubMed ID: 9601759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment.
    Meduri GU; Tolley EA; Chinn A; Stentz F; Postlethwaite A
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1432-41. PubMed ID: 9817690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. With a note on published results in encephalopathic patients.
    Shumaker JB; Resnick RH; Galambos JT; Makopour H; Iber FL
    Am J Gastroenterol; 1978 Apr; 69(4):443-9. PubMed ID: 356593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice.
    Pelletier G; Roulot D; Davion T; Masliah C; Causse X; Oberti F; Raabe JJ; Van Lemmens C; Labadie H; Serfaty L;
    Hepatology; 2003 Apr; 37(4):887-92. PubMed ID: 12668982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
    Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
    Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroid therapy in severe alcoholic hepatitis. A double-blind drug trial.
    Porter HP; Simon FR; Pope CE; Volwiler W; Fenster LF
    N Engl J Med; 1971 Jun; 284(24):1350-5. PubMed ID: 4930603
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial.
    Conchillo M; de Knegt RJ; Payeras M; Quiroga J; Sangro B; Herrero JI; Castilla-Cortazar I; Frystyk J; Flyvbjerg A; Yoshizawa C; Jansen PL; Scharschmidt B; Prieto J
    J Hepatol; 2005 Oct; 43(4):630-6. PubMed ID: 16024131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of colchicine in alcoholic cirrhosis: final results of a double blind randomized trial.
    Cortez-Pinto H; Alexandrino P; Camilo ME; Gouveia-Oliveira A; Santos PM; Alves MM; Moura MC
    Eur J Gastroenterol Hepatol; 2002 Apr; 14(4):377-81. PubMed ID: 11943949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of glucocorticoids in sodium retention in cirrhotic patients: a double blind, randomized, crossover study.
    Højmark Hansen M; Kristensen SS; Schaffalitzky de Muckadell OB; Thiesson HC; Andrew R; Dam Fialla A
    Scand J Gastroenterol; 2012 Sep; 47(8-9):1030-6. PubMed ID: 22670598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of treatment with paromomycin on endotoxemia in patients with alcoholic liver disease--a double-blind, placebo-controlled trial.
    Bode C; Schäfer C; Fukui H; Bode JC
    Alcohol Clin Exp Res; 1997 Nov; 21(8):1367-73. PubMed ID: 9394106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prednisolone on local and systemic response in laparoscopic vs. open colon surgery: a randomized, double-blind, placebo-controlled trial.
    Vignali A; Di Palo S; Orsenigo E; Ghirardelli L; Radaelli G; Staudacher C
    Dis Colon Rectum; 2009 Jun; 52(6):1080-8. PubMed ID: 19581850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative methylprednisolone enhances recovery after endovascular aortic repair: a randomized, double-blind, placebo-controlled clinical trial.
    de la Motte L; Kehlet H; Vogt K; Nielsen CH; Groenvall JB; Nielsen HB; Andersen A; Schroeder TV; Lönn L
    Ann Surg; 2014 Sep; 260(3):540-8; discussion 548-9. PubMed ID: 25115430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis. Results of a randomized, double-blind, placebo-controlled clinical study.
    Lucena MI; Andrade RJ; de la Cruz JP; Rodriguez-Mendizabal M; Blanco E; Sánchez de la Cuesta F
    Int J Clin Pharmacol Ther; 2002 Jan; 40(1):2-8. PubMed ID: 11841050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial.
    Carithers RL; Herlong HF; Diehl AM; Shaw EW; Combes B; Fallon HJ; Maddrey WC
    Ann Intern Med; 1989 May; 110(9):685-90. PubMed ID: 2648927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylprednisolone and ketorolac rapidly reduce hyperalgesia around a skin burn injury and increase pressure pain thresholds.
    Stubhaug A; Romundstad L; Kaasa T; Breivik H
    Acta Anaesthesiol Scand; 2007 Oct; 51(9):1138-46. PubMed ID: 17714578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of colchicine and steroids in the treatment of alcoholic liver disease.
    Galambos JT; Riepe SP
    Recent Dev Alcohol; 1984; 2():181-94. PubMed ID: 6374780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylprednisolone, valacyclovir, or the combination for vestibular neuritis.
    Strupp M; Zingler VC; Arbusow V; Niklas D; Maag KP; Dieterich M; Bense S; Theil D; Jahn K; Brandt T
    N Engl J Med; 2004 Jul; 351(4):354-61. PubMed ID: 15269315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.
    Mato JM; Cámara J; Fernández de Paz J; Caballería L; Coll S; Caballero A; García-Buey L; Beltrán J; Benita V; Caballería J; Solà R; Moreno-Otero R; Barrao F; Martín-Duce A; Correa JA; Parés A; Barrao E; García-Magaz I; Puerta JL; Moreno J; Boissard G; Ortiz P; Rodés J
    J Hepatol; 1999 Jun; 30(6):1081-9. PubMed ID: 10406187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No effect of long-term oral testosterone treatment on liver morphology in men with alcoholic cirrhosis.
    Gluud C; Christoffersen P; Eriksen J; Wantzin P; Knudsen BB
    Am J Gastroenterol; 1987 Jul; 82(7):660-4. PubMed ID: 3300274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial.
    Parés A; Planas R; Torres M; Caballería J; Viver JM; Acero D; Panés J; Rigau J; Santos J; Rodés J
    J Hepatol; 1998 Apr; 28(4):615-21. PubMed ID: 9566830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.